Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis
Restricted accessResearch articleFirst published online September, 2022
Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis
The aims of this systematic review were: (1) to investigate the prophylactic effect of radiotherapy (RT) and NSAIDs in high-risk patients following total hip arthroplasty (THA); and (2) to compare the efficacy of non-selective and COX-II selective NSAIDs in preventing post-THA HO, utilising a meta-analysis of randomised control studies.
Methods:
The PubMed, Embase, and Cochrane Databases were searched for articles regarding HO following THA in March 2019. Studies were included if they contained data regarding HO incidence after THA or contained data regarding HO prophylaxis comparison of NSAIDs and/or RT in terms of dosage or duration.
Results:
24 studies reported on populations that were not at high-risk for HO. These studies reported between 47.3% and 90.4% of their patient populations had no HO formation; between 2.8% and 52.7% had mild formation; and between 0.0% and 10.4% had severe formation. A total of 13 studies reported on populations at high-risk for HO. Studies analysing RT in high-risk patients reported between 28.6% and 97.4% of patients developed no HO formation; between 1.9% and 66.7% developed mild HO formation; and between 0.0% and 11.9% developed severe HO formation. Studies analysing NSAID treatment among high-risk populations reported between 76.6% and 88.9% had no HO formation; between 11.1% and 23.4% had mild HO formation, and between 0.0% and 1.8% had severe HO formation. 9 studies were identified as randomised control trials and subsequently used for meta-analysis. The relative risk for COX-II in developing any HO after THA was not significantly different compared to non-selective NSAIDs (RR 1.00; CI, 0.801–1.256; p = 0.489).
Conclusions:
NSAIDs prophylaxis for HO may have better efficacy than RT in high-risk patients following THA. Non-selective and COX-II selective NSAIDs have comparable efficacy in preventing HO. Factors such as medical comorbidities and side-effect profile should dictate the prophylaxis recommendation.
IorioRHealyWL.Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg2002; 10: 409–416.
2.
SundaramNAMurphyJC.Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis. Clin Orthop Relat Res1986; 207: 223–226.
3.
AhrengartLLindgrenU.Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop Relat Res1993; 293: 153–159.
4.
ZhuYZhangFChenW, et al. Incidence and risk factors for heterotopic ossification after total hip arthroplasty: a meta-analysis. Arch Orthop Trauma Surg2015; 135: 1307–1314.
5.
RitterMAVaughanRB.Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am1977; 59: 345–351.
6.
DeLeeJFerrariACharnleyJ.Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop Relat Res1976; 121: 53–59.
7.
NealBGrayHMacMahonS, et al. Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg2002; 72: 808–821.
8.
PellegriniJVJrKonskiAAGastelJA, et al. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field. J Bone Joint Surg Am1992; 74: 186–200.
9.
CoventryMBScanlonPW.The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg Am1981; 63: 201–208.
10.
AyersDCEvartsCMParkinsonJR.The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg Am1986; 68: 1423–1430.
11.
HealyWLLoTCCovallDJ, et al. Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty1990; 5: 369–375.
12.
HedleyAKMeadLPHendrenDH.The prevention of heterotopic bone formation following total hip arthroplasty using 600 rad in a single dose. J Arthroplasty1989; 4: 319–325.
13.
Kjaersgaard-AndersenPSchmidtSA.Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification. Clin Orthop Relat Res1991; 263: 78–86.
14.
SchmidtSAKjaersgaard-AndersenPPedersenNW, et al. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J Bone Joint Surg Am1988; 70: 834–838.
15.
AmstutzHCFowbleVASchmalzriedTP, et al. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty. J Arthroplasty1997; 12: 126–132.
16.
KnellesDBarthelTKarrerA, et al. Prevention of heterotopic ossification after total hip replacement: a prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg Br1997; 79: 596–602.
17.
Kjaersgaard-AndersenPRitterMA.Prevention of formation of heterotopic bone after total hip arthroplasty. J Bone Joint Surg Am1991; 73: 942–947.
18.
CellaJPSalvatiEASculcoTP.Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty: effectiveness, contraindications, and adverse effects. J Arthroplasty1988; 3: 229–234.
19.
WurnigCAuerspergVBoehlerN, et al. Short term prophylaxis against heterotopic bone after cementless hip replacement. Clin Orthop Relat Res1997; 334: 175–183.
20.
van der HeideHJKoorevaarRTSchreursBW, et al. Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty. J Arthroplasty1999; 14: 796–799.
21.
FranceschiCCampisiJ.Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Ser Biomed Sci Med Sci2014; 69(Suppl. 1): S4–S9.
22.
DenkoCWBojaBMalemudCJ.Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci2002; 7: a37–a43.
HarirforooshSAsgharWJamaliF.Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci2013; 16: 821–847.
25.
StrandV.Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?Lancet2007; 370: 2138–2151.
26.
AnthonyPKeysHEvartsCM, et al. Prevention of heterotopic bone formation with early post operative irradiation in high risk patients undergoing total hip arthroplasty: comparison of 10.00 Gy vs 20.00 Gy schedules. Int J Radiat Oncol Biol Phys1987; 13: 365–369.
27.
BarthelTBaumannBNöthU, et al. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand2002; 73: 611–614.
28.
BrunnekreefJJHoogervorstPPloegmakersMJ, et al. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?Int Orthop2013; 37: 583–587.
29.
ChaoSTLeeSYBordenLS, et al. External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification. J Arthroplasty2006; 21: 731–736.
30.
DornUGrethenCEffenbergerH, et al. Indomethacin for prevention of heterotopic ossification after hip arthroplasty: a randomized comparison between 4 and 8 days of treatment. Acta Orthop Scand1998; 69: 107–110.
31.
ElmstedtELindholmTSNilssonOS, et al. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand1985; 56: 25–27.
32.
FranchinFSanguinetiFCaioneG.Preliminary study of rofecoxib (25 mg) in prevention of heterotopic ossification after total hip replacement. J Orthopaed Traumatol2004; 5: 77–80.
33.
FransenMAndersonCDouglasJ, et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ2006; 333: 519.
34.
GebuhrPSoelbergMOrsnesT, et al. Naproxen prevention of heterotopic ossification after hip arthroplasty: a prospective control study of 55 patients. Acta Orthop Scand1991; 62: 226–229.
35.
GregoritchSJChadhaMPelligriniVD, et al. Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results. Int J Radiat Oncol Biol Phys1994; 30: 55–62.
36.
GrohsJGSchmidtMWanivenhausA.Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop2007; 78: 95–98.
37.
GünalIHazerBSeberS, et al. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients. Acta Orthop Scand2001; 72: 467–469.
38.
HoikkaVLindholmTSEskolaA.Flurbiprofen inhibits heterotopic bone formation in total hip arthroplasty. Arch Orthop Trauma Surg1990; 109: 224–226.
39.
JockheckMWillmsRVolkmannR, et al. Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac. Arch Orthop Trauma Surg1998; 117: 337–340.
40.
KoelblOSeufertJPohlF, et al. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement. Strahlenther Onkol2003; 179: 767–773.
41.
KölblOKnellesDBarthelT, et al. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement. Int J Radiat Oncol Biol Phys1997; 39: 961–966.
42.
K̈ölblOKnellesDBarthelT, et al. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial. Int J Radiat Oncol Biol Phys1998; 42: 397–401.
43.
KonskiAPellegriniVPoulterC, et al. Randomized trial comparing single dose versus fractionated irradiation for prevention of heterotopic bone: a preliminary report. Int J Radiat Oncol Biol Phys1990; 18: 1139–1142.
44.
LaverniaCJContrerasJSVillaJM, et al. Celecoxib and heterotopic bone formation after total hip arthroplasty. J Arthroplasty2014; 29: 390–392.
45.
van LeeuwenWMDeckersPde LangeWJ.Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty: a randomized study in 62 hips. Acta Orthop Scand1998; 69: 116–118.
46.
LegensteinRBöschPUngersböckA.Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Arch Orthop Trauma Surg2003; 123: 91–94.
47.
NealBCRodgersAGrayH, et al. No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients. Acta Orthop Scand2000; 71: 129–134.
48.
OniJKPineroJRSaltzmanBM, et al. Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study. Hip Int2014; 24: 256–262.
49.
PadgettDEHolleyKGCummingsM, et al. The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study. J Arthroplasty2003; 18: 677–686.
50.
PakosEEStafilasKSTsekerisPG, et al. Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty. Strahlenther Onkol2009; 185: 500–505.
51.
PerssonPESodemannBNilssonOS.Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty: a randomized double-blind prospective study of treatment time. Acta Orthop Scand1998; 69: 111–115.
52.
PritchettJW.Ketorolac prophylaxis against heterotopic ossification after hip replacement. Clin Orthop Relat Res1995; 314: 162–165.
53.
RomanòCLDuciDRomanòD, et al. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty2004; 19: 14–18.
54.
SaudanMSaudanPPernegerT, et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement. J Bone Joint Surg Br2007; 89: 155–159.
55.
SeegenschmiedtMHGoldmannARWölfelR, et al. Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy. Radiother Oncol1993; 26: 271–274.
56.
SellSWillmsRJanyR, et al. The suppression of heterotopic ossifications: radiation versus NSAID therapy–a prospective study. J Arthroplasty1998; 13: 854–859.
57.
SellSPhillipsOHandelM.No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty. Acta Orthop Scand2004; 75: 45–49.
58.
van der HeideHJRijnbergWJVan SorgeA, et al. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. Acta Orthop2007; 78: 90–94.
59.
VielpeauCJoubertJMHuletC.Naproxen in the prevention of heterotopic ossification after total hip replacement. Clin Orthop Relat Res1999; 369: 279–288.
60.
WengHKWuPKChenCF, et al. Total hip arthroplasty for patients who have ankylosing spondylitis: is postoperative irradiation required for prophylaxis of heterotopic ossification?J Arthroplasty2015; 30: 1752–1756.
61.
WinklerSSpringorumHRVaitlT, et al. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac. Int Orthop2016; 40: 673–680.
62.
VavkenPCastellaniLSculcoTP.Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis. Clin Orthop Relat Res2009; 467: 3283–3289.
63.
NealB.Effects of heterotopic bone formation on outcome after hip arthroplasty. ANZ J Surg2003; 73: 422–426.
64.
JoiceMVasileiadisGIAmanatullahDF.Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis. Bone Joint J2018; 100–B: 915–922.
65.
HarrisJDBrandJCCoteMP, et al. Research pearls: the significance of statistics and perils of pooling. Part 3: pearls and pitfalls of meta-analyses and systematic reviews. Arthrosc J2017; 33: 1594–1602.
66.
KanSLYangBNingGZ, et al. Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty: a systematic review and meta-analysis. Medicine (Baltimore)2015; 94: e828.
